Apremilast has neutral effect on vascular inflammation in psoriasis studyApril 8, 2022Psoriatic Arthritis
Slight improvement in axial PsA with DMARD therapy irrespective of HLA-B27 statusMarch 24, 2022Psoriatic Arthritis
Effect of burdensome symptoms on treatment preferences of patients with PsAMarch 24, 2022Psoriatic Arthritis
Secukinumab shows a satisfactory retention rate in PsA in real-world settingMarch 24, 2022Psoriatic Arthritis
Degree of disease control influences abnormalities in renal parameters in PsAMarch 24, 2022Psoriatic Arthritis
Degree of disease control influences abnormalities in renal parameters in PsAMarch 24, 2022Psoriatic Arthritis
Scoring by MRI is an effective way to identify change in clinical outcomes of PsAMarch 24, 2022Psoriatic Arthritis
Reduced humoral response to SARS-CoV-2 vaccine in patients receiving systemic therapy for PsAMarch 24, 2022Psoriatic Arthritis
PsA: Comparable efficacy, safety, and persistence with TNFi or ustekinumab in real worldMarch 24, 2022Psoriatic Arthritis
PsA: Methotrexate+leflunomide more effective but less well tolerated than methotrexate monotherapyMarch 24, 2022Psoriatic Arthritis
Introducing adalimumab vs. escalating methotrexate in patients with inadequately controlled PsAMarch 24, 2022Psoriatic Arthritis
